Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-25 @ 2:26 PM
NCT ID:
NCT01119066
Group ID:
EG001
Title:
Busulfan, Melphalan and Fludarabine
Description:
Busulfan (0.8 mg/kg every 6 hours x 10 or 12 doses), (depending on disease) with dose modified according to pharmacokinetics Melphalan (70mg/m2/day x 2 ) Fludarabine (25mg/m2/ day x 5)
Busulfan: 0.8 mg/kg every 6 hours x 10 or 12 doses (depending on disease) with dose modified according to pharmacokinetics
Melphalan: 70mg/m2/day x 2
Fludarabine: 25mg/m2/ day x 5
(CliniMACS) T-cell depleted PBSC Transplant
Deaths Number Affected:
71
Deaths Number At Risk:
None
Serious Number Affected:
30
Serious Number At Risk:
213
Other Number Affected:
31
Other Number At Risk:
213
Study:
NCT01119066
Results Section:
NCT01119066
Adverse Events Module:
NCT01119066